Why the study?
Does an infrarenal neck length <15 mm increase the risk of proximal endoleaks in patients undergoing endovascular abdominal aortic aneurysm repair?
Does an infrarenal neck length <15 mm increase the risk of proximal endoleaks in patients undergoing endovascular abdominal aortic aneurysm repair?
Endovascular treatment of abdominal aortic aneurysms with an infrarenal neck length <15 mm is associated with a significantly increased risk of short- and midterm proximal endoleaks.
Answers are grounded in this paper and cite their sources.
Short infrarenal necks warrant caution in EVAR planning; leaves open whether adjunctive strategies improve outcomes in prospective studies.
PURPOSE: To evaluate the influence of the infrarenal neck length on clinical outcome after endovascular abdominal aortic aneurysm repair (EVAR). METHODS: Data were analyzed from 3499 patients enrolled in the EUROSTAR registry between January 1999 and April 2005 who underwent EVAR with a Talent or Zenith endograft and had detailed morphological data recorded. The study cohort was divided into 3 groups according to infrarenal neck length: >15 mm (reference group A, n=2822), 11 to 15 mm (group B, n=485), and < or =10 mm (group C, n=192). Uni- and multivariate analyses were performed to evaluate differences in clinical outcomes among the study groups. RESULTS: After correction for confounders, proximal type I endoleak within 30 days occurred in 10.9% of group C compared to 2.6% of group A (OR 4.46, 95% CI 2.61 to 7.61). Within 48 months of follow-up (median 12 months), the incidence of proximal endoleaks was higher in groups B (9.6%; HR 1.98, 95% CI 1.16 to 3.38) and C (11.3%; HR 2.132, 95% CI 1.17 to 4.60) compared to group A (3.4%). CONCLUSION: Our study indicates that endovascular treatment of abdominal aortic aneurysms with infrarenal neck length <15 mm is associated with significantly increased risk of short- and midterm proximal endoleaks after EVAR. The greater risk of proximal endoleaks should be weighed against the risks of alternative treatment modalities.
No takes yet. Share an insight, caveat, or question.
Leurs et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: